Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1990-01-10
1992-01-21
Brown, Johnnie R.
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
536 71, 536 187, 536 23, 536 181, C07H 1700
Patent
active
050829335
ABSTRACT:
A new antibiotic designated BMY-42448 is produced by fermentation of Micromonospora narashinoensis strain C39217-R109-7 (ATCC-53791). BMY-42448 exhibits both in vitro and in vivo antitumor activity.
REFERENCES:
patent: Re32034 (1985-11-01), Chabala
patent: 4550160 (1985-10-01), Mrozik
Tomita, F. et al., J. Antibiot., 33, 668, 940, 946 (1980); Waitz, J. A. et al., J. Antibiotics, 34, 1101 (1981); Mallams, A. K. et al.
J. Am. Chem. Soc. 103, 3938, 3940 (1981); Muntwyler, R. et al. Helv. Chem. Acta, 55, 2071 (1972).
Berry Ronald L.
Gustavson Donald R.
Hesler Grace A.
Lam Kin S.
Schroeder Daniel R.
Bristol-Myers Squibb Co.
Brown Johnnie R.
Webber Pamela S.
Yang Mollie M.
LandOfFree
Antitumor antibiotic BMY-42448 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antitumor antibiotic BMY-42448, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antitumor antibiotic BMY-42448 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-116453